Andere Sprachen Alcon Inc.

Aktien

A2PDXE

CH0432492467

ALC

Medizinische Versorgung

Realtime-Estimate Cboe Europe Andere Börsenplätze 15:00:24 09.07.2025			% 5 Tage	% 1. Jan.
69,04 ^CHF	-0,23 %		-2,38 %	-10,25 %

08.07.	Aktien Schweiz schaffen knappen Sprung ins Plus	DJ
08.07.	Alcons neueste bahnbrechende Operationstechnologie, Unity VCS, erhält Zulassung von Health Canada	CI

Andere Sprachen

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration	08.07.
Alcon's Latest Breakthrough Surgical Technology, Unity VCS, Receives Health Canada Approval	08.07.
Alcon Gets Health Canada Approval on Unity Vitreoretinal Cataract System	08.07.
Alcon étoffe sa direction	08.07.
La dernière technologie chirurgicale révolutionnaire d’Alcon, Unity VCS, reçoit l’approbation de Santé Canada	08.07.
Alcon : Names Julie M. Brewer to its Executive Leadership Team as SVP, President, Global Franchises	08.07.
Alcon Eyes Vitreoretinal Surgery Market Expansion in LumiThera Deal	08.07.
Swiss Stocks Kicks Off Week in Red; All Eyes on US Tariffs as Deadline Looms	07.07.
Alcon: acquisition of LumiThera and its photobiomodulation technology	07.07.
Alcon to Buy LumiThera, Photobiomodulation Device for Age-Related Macular Degeneration Treatment	07.07.
Alcon acquisisce Lumithera	07.07.
Swiss-listed Alcon Plans Acquisition of US-based LumiThera	07.07.
Alcon s'offre un dispositif contre la dégénérescence maculaire	07.07.
Alcon to acquire Lumithera	07.07.
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)	07.07.
Alcon Inc. announced its intention to acquire LumiThera, Inc.	07.07.
Alcon Canada reçoit une reconnaissance mondiale comme l’un des meilleurs employeurs	26.06.
Championing Patient-Focused Innovation: Alcon Highlights Recently Approved TRYPTYR, MARLO Advancements and More at Optometry’s Meeting 2025	25.06.
Alcon Introduces Clareon PanOptix Pro in Canada, Delivering Low Light Scatter of Any Trifocal IOL	20.06.
Alcon annonce l’arrivée de Clareon PanOptix Pro au Canada, une lentille intraoculaire réduisant la dispersion de la lumière comme aucune autre LIO trifocale	20.06.
Ricerca e sviluppo: le grandi aziende rallentano gli investimenti	18.06.
Cooper Companies raises 2025 profit forecast on contact lens demand	29.05.
US FDA approves Alcon's new dry-eye drug (May 28)	29.05.
US FDA Approves Alcon's Dry Eye Disease Treatment	29.05.
Alcon Announces FDA Approval of TRYPTYR (acoltremon Ophthalmic Solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease	28.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

ALCON : Das erste Quartal blieb hinter den Erwartungen zurück; Prognose gesenkt

Am 14. Mai 2025 um 14:56 Uhr